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Introduction {#sec004}
============

Visceral leishmaniasis (VL), caused by protozoan parasite *Leishmania donovani*, is the most severe form of leishmaniasis. After infection, the parasite migrates to internal organs such as liver, spleen and bone marrow, followed by appearance of complex clinical symptoms, which can be lethal, if left untreated \[[@pone.0124559.ref001], [@pone.0124559.ref002]\]. In Indian subcontinent, (India, Nepal and Bangladesh) approximately 150 million people are at risk of developing VL (67% of the world VL disease) \[[@pone.0124559.ref003]--[@pone.0124559.ref005]\]. It is considered to be a rural disease and is a big burden for the people, who are in the villages of Bihar state in India \[[@pone.0124559.ref003], [@pone.0124559.ref006], [@pone.0124559.ref007]\]. Genetic, immunological and socio-economical factors play a role in the disease outcome \[[@pone.0124559.ref006]--[@pone.0124559.ref009]\].

Human Interleukin-10 (IL10) gene, located on chromosomal region 1q32.1, codes for anti-inflammatory cytokine. IL10 comprises of 5 exons, covering approximately 4.8 kb ([Fig 1](#pone.0124559.g001){ref-type="fig"}). IL10 cytokine is primarily produced by monocytes and to a lesser extent by lymphocytes; namely type 2 T helper cells (Th2), mastocytes, CD4^+^CD25^+^Foxp3^+^ regulatory T cells, and a certain subset of activated T cells and B cells \[[@pone.0124559.ref010]\]. It is also expressed by different cells of the innate immune system, including dendritic cells (DCs), mast cells, natural killer (NK) cells, eosinophils and neutrophils \[[@pone.0124559.ref011]\]. IL10 down regulates the expression of Th1 cytokines, major histocompatibility complex II (MHC II), co-stimulatory molecules on macrophages and IL-12 \[[@pone.0124559.ref012],[@pone.0124559.ref013]\]. IL10 has a stimulatory effect on certain T cells (Th2), mast cells and it stimulates the B cell survival, proliferation and antibody production \[[@pone.0124559.ref012], [@pone.0124559.ref014], [@pone.0124559.ref015]\]. It is also involved in the regulation of the STAT (Signal transducer and activator of transcription) signalling pathway and inhibit intracellular killing of amastigotes by macrophages \[[@pone.0124559.ref016], [@pone.0124559.ref017]\].

![The structure of the human *IL10* (chr1, 206945839--206940947; ENST00000423557).\
Exons of the gene are shown in pink, introns in brown. rs1518111 (2195 A\>G) and rs1554286 (2607 C\>T) were the intronic variant of second and third exons while rs3024496 (4976 T\>C) and rs3024498 (5311 A\>G) were the 3' UTR variant of fifth exons.](pone.0124559.g001){#pone.0124559.g001}

IL10 plays key role in different diseases, such as; hepatitis B, pulmonary tuberculosis, herpes zoster, cutaneous malignant melanoma, skin squamous cell carcinoma, inflammatory bowel diseases, human immuno deficiency viruses (HIV), leprosy, schistosomiasis, malaria, filaria and rheumatoid arthritis \[[@pone.0124559.ref018]--[@pone.0124559.ref029]\]. IL10 is also widely studied in organ transplantation \[[@pone.0124559.ref022], [@pone.0124559.ref030]\]. VL patients display over expression of IL10 mRNA and high level of IL10 in blood serum \[[@pone.0124559.ref010], [@pone.0124559.ref031]\] (reviewed in \[[@pone.0124559.ref012]\]). Recent studies on Indian VL demonstrated that disease outcome depends possibly on the balance between pro-inflammatory cytokines (IFN-γ and TNF-α) and anti-inflammatory (IL-10) responses \[[@pone.0124559.ref032], [@pone.0124559.ref033]\]. Subsequent studies have shown that the functional IL10 polymorphisms are also associated with pulmonary tuberculosis and leprosy in Indian population \[[@pone.0124559.ref019], [@pone.0124559.ref025]\]. Earlier genetic studies in Sudan, Brazil and Iran have shown the role of IL10 polymorphisms in visceral leishmaniasis (VL), cutaneous leishmaniasis (CL) and post kala-azar dermal leishmaniasis (PKDL) respectively \[[@pone.0124559.ref034]--[@pone.0124559.ref036]\]. However, to the best of our knowledge no attempt has been made to investigate the role of *IL10* in Indian VL. Therefore, we have investigated the complete *IL10* in ethnically matched VL case-controls. Considering the fact that, VL is endemic in Bihar state of India and every Indian population is genetically unique \[[@pone.0124559.ref037]\], we have also aimed to investigate the distribution of risk / protective / severe alleles, observed by the case-control study, among the 34 diverse population of India.

Materials and Methods {#sec005}
=====================

Sample collection {#sec006}
-----------------

A total of 356 subjects, including 184 VL patients and 172 ethnically matched controls in the Middle Eastern part of India (Bihar state) were included in this study ([Table 1](#pone.0124559.t001){ref-type="table"}). The sampling area were located within a radius of \~80 kilometer from the city of Muzaffarpur covering the districts of Muzaffarpur, Patna, Vaisali and Sitamadhi VL endemic regions. The demographic details of the study region and an annual incidence rate of 2.49 clinical VL cases/1,000 persons have been described elsewhere \[[@pone.0124559.ref038], [@pone.0124559.ref039]\].

10.1371/journal.pone.0124559.t001

###### Sample size, mean age and sex ratio of case and control samples.
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                         Case (184)        Control (172)     P-value
  ---------------------- ----------------- ----------------- ---------
  Mean Age (year)+/-SD   29.38 +/- 17.11   38.79 +/- 16.57   0.33581
  Male: Female           102:82            97:75             0.9397

Patients were recruited upon visiting their residence and screening their medical records, issued by the local government hospitals. Diagnosis of VL was performed at the hospitals by serological (rK39 strip test) and parasitological methods (light microscopy) using splenic aspirates accompanied by typical clinical features such as; fever, weight loss, fatigue, anaemia, hepatomegaly, splenomegaly and presence of clinical response to anti-leishmanial treatment \[[@pone.0124559.ref001]\]. Control subjects were recruited from the same geographical region and matched for age, sex and ethnicity. Both, case and controls are Indo-European speakers and are socially classified as caste populations. The controls were healthy subjects, who have never been diagnosed with VL and did not show any family history of VL from the last three generations. The health status of the control subjects were examines with the help of local health authority and confirmed that they are healthy. Further, they also confirmed that the healthy subjects were also free from other infectious diseases (TB, filaria, malaria, etc.) of same geographical region. The mean age of all cases was 29.38 +/- 17.11, while controls ranged from 38.79 +/- 16.57 ([Table 1](#pone.0124559.t001){ref-type="table"}). The male to female ratio in cases was 102:82 and in controls was 97:75 ([Table 1](#pone.0124559.t001){ref-type="table"}). From each subject, we have collected 3--5.0 mL of peripheral blood samples in EDTA vacutainer, with informed written consent. Prior permission was also obtained from the district government authority. This study was approved by the Institutional Ethical Committee (IEC) of CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India. In addition to case controls, a total of 1138 individuals from 34 ethnic populations belonging to different social (16 tribal population and 18 caste populations) and linguistic groups (Indo-European, Dravidian, and Austro-Asiatic); and inhabited in different geographical regions, were also included in this study). These samples were utilized from the DNA bank of CCMB (Centre for Cellular and Molecular Biology, Hyderabad).

DNA isolation and IL10 genotyping {#sec007}
---------------------------------

Genomic DNA was extracted from whole blood, using the protocol described previously \[[@pone.0124559.ref040]\]. Reference genomic sequence was retrieved from the Ensembl database \[[www.ensembl.org](http://www.ensembl.org/)\]. Primers for PCR and sequencing of five exons and exon-intron boundary were designed using Primer-BLAST (<http://www.ncbi.nlm.nih.gov/tools/primer-blast>) and synthesized commercially (Eurofins, India) ([Table 2](#pone.0124559.t002){ref-type="table"}).

10.1371/journal.pone.0124559.t002

###### Primer sequence, GC % and annealing temperature of *IL10* exons.
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  Primer        Sequence                      GC%   Tm   Annealing temperature
  ------------- ----------------------------- ----- ---- -----------------------
  IL10_1F       GGTTAGAGAAGGAGGAGCTCTAAGCA    50    60   
  IL10_1R       GGCGCAGGAGGAGGGTTCTT          65    58   60
  IL10_2F       GGGCATCAAAAAGACCGCATTTCAGT    46    58   
  IL10_2R       TGTCCCTGCTGGTCTGTAGGA         57    56   58
  IL10_3 & 4F   TCCCAGGGCCATGGAAGCAG          65    58   
  IL10_3 & 4R   TGCACGTGTGGGTTCAGCCT          60    56   58
  IL10_5AF      TCCCAGCGTGAGGGAGAACA          60    56   
  IL10_5AR      GCGCCCGGCCTAGAACCAAA          65    58   58
  IL10_5BF      GTTGAGCTGTTTTCCCTGACCTCCC     56    61   
  IL10_5BR      GTCAGACAAGAGTCAACTGACACCAGA   48    60   61
  IL10_5CF      CCTAAATTTGGTTCTAGGCCGGGCG     56    61   
  IL10_5CR      TAGGGGGTAGCTGGCTTCCTTTCTC     56    61   61

We have amplified the target regions using primer pairs ([Table 2](#pone.0124559.t002){ref-type="table"}) and an Emerald PCR master mix (TaKaRa). The reactions were carried out in an ABI GeneAmp PCR system 9700. The thermal cycling parameters used were as follows: initial denaturation at 95°C for 5 minutes, followed by 35 cycles of denaturation at 94°C for 1 minute, annealing for 30 seconds and elongation at 72°C for 1 minute ([Table 2](#pone.0124559.t002){ref-type="table"}). PCR amplification was followed by Exo-SAP treatment (USB Corporation, USA), following manufacturer's protocol. Exo-SAP treated amplicons were sequenced directly using BigDye terminator (v.3.1) cycle sequencing kit (Applied Biosystems, USA) on an ABI 3730XL DNA analyser. Sequence variations were identified by assembling DNA sequences with the reference sequence using AutoAssembler software (Applied Biosystems, USA). Variations obtained were validated and reconfirmed in a subset of samples by re-sequencing and visual confirmation of electropherograms.

Statistical analysis {#sec008}
--------------------

The target sample size was determined using PS software (Power and Sample Size Calculation Software Package, Vanderbilt University, Nashville, TN). The allele and genotype frequencies were calculated by simple gene counting method and Expectation Maximum (EM) algorithm. Hardy-Weinberg equilibrium and Chi-square tests were computed using PLINK software (Purcell et. al, 2007, options used:---assoc,---hwe 0.01). p value of \< 0.05 was considered significant. Further, p value was corrected for multiple testing and adjusted as function of R base package \[[@pone.0124559.ref041]\]. Linkage disequilibrium (LD) analysis was performed using Haploview (v4.2). In addition, genetic models such as allelic, dominant and recessive were examined to evaluate the distribution of the genotype and allelic frequencies. *In-silico* methods were used to predict miRNA binding sites for wild and mutant (rs3024498) mRNA, using RegRNA online tool.

Results {#sec009}
=======

We estimated that 184 cases and 172 controls were required for each study to achieve 88% power, with 95% confidence, and 5% precision to detect a variable with an odds ratio of 2.0 (based on the assumption of 30% exposure among controls). Further, we have investigated the entire coding region of *IL10* in study subjects, with non-significant difference in age and gender distribution ([Table 1](#pone.0124559.t001){ref-type="table"}), and found four variations (SNPs): rs1518111 (2195 A\>G, intron 2; chr1:206945616), rs1554286 (2607 C\>T, intron 3; chr1:206944233), rs3024496 (4976 T\>C, 3' UTR; chr1:206941864) and rs3024498 (5311 A\>G, 3' UTR; chr1:206941529) ([Fig 1](#pone.0124559.g001){ref-type="fig"}; [Table 3](#pone.0124559.t003){ref-type="table"}). Of which, 5311 A\>G in 3' UTR is associated with visceral leishmaniasis by logistic regression analysis ([Table 3](#pone.0124559.t003){ref-type="table"}). Suggesting that allele A is significantly associated with visceral leishmaniasis (χ^2^ = 18.87; p = 0.00001, OR = 0.515; CI = 0.382--0.696) ([Table 3](#pone.0124559.t003){ref-type="table"} and Fig [2A](#pone.0124559.g002){ref-type="fig"} and [2B](#pone.0124559.g002){ref-type="fig"}). However, the 'G' allele is significantly reducing risk of VL ([Table 3](#pone.0124559.t003){ref-type="table"}, [Fig 2B](#pone.0124559.g002){ref-type="fig"}). The genotype distribution (%) of 5311 A\>G in VL cases were 49.46 (AA), 29.89 (AG), 20.65 (GG), while in control they were 26.74 (AA), 43.02 (AG), 30.24 (GG) ([Table 3](#pone.0124559.t003){ref-type="table"} and [Fig 2A](#pone.0124559.g002){ref-type="fig"}). All the studied polymorphisms were in HWE for control subjects. Of these, GG (χ^2^ = 12.97; p = 0.00032, OR = 0.369; CI = 0.213--0.639) and AG (χ^2^ = 15.18; p = 0.00010, OR = .376; CI = 0.228--0.618) genotypes were significantly associated with protection against VL. Similarly, distributions of allele A was 64.40%, and G was 35.60% in cases; while in controls it was 48.26% (A), and 51.75% (G). Further, of the four SNPs studied, two (rs1554286 and rs1518111) were in LD in both cases (r2 = 0.78) and controls (r2 = 0.84) ([Fig 3](#pone.0124559.g003){ref-type="fig"}).

![A. Distribution of genotype frequencies for*IL10* polymorphism, rs1518111 A\>G; rs1554286 C\>T; rs3024496 C\>T and rs3024498 A\>G in VL case and control subjects\
. B. Distribution of allele frequencies for *IL10* polymorphism, rs1518111 A\>G; rs1554286 C\>T; rs3024496 C\>T and rs3024498 A\>G in VL case and control subjects.](pone.0124559.g002){#pone.0124559.g002}

![Linkage Disequilibrium (LD) of studied *IL-10* loci rs1518111 (2195 A\>G, intron), rs1554286 (2607 C\>T, intron), rs3024496 (4976 T\>C, 3' UTR), rs3024498 (5311 A\>G, 3' UTR) in VL case and control groups.](pone.0124559.g003){#pone.0124559.g003}
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###### Distribution of *IL10* genotype and alleles in cases and controls of visceral leishmaniasis.
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  SNP ID      Genotype     No. of Case (%)   No. of Controls (%)   OR             (95% CI)   χ^2^ Value   P- Value   Adjusted P-Value
  ----------- ------------ ----------------- --------------------- -------------- ---------- ------------ ---------- ------------------
  rs1518111   AA           32(17.39)         33(19.19)             Ref                                               
  AG          83(45.11)    77(44.77)         1.112                 0.624--1.979   0.13       0.71912                 
  GG          69(37.50)    62(36.04)         1.148                 0.633--2.081   0.21       0.64996                 
  A           147(39.95)   143(41.57)        Ref                                                                     
  G           221(60.05)   201(58.43)        1.07                  0.793--1.443   0.19       0.65938                 
  rs1554286   CC           60(32.60)         56(32.56)             Ref                                               
  CT          82(44.57)    74 (43.02)        1.034                 0.639--1.673   0.02       0.89091                 
  TT          42(22.83)    42(24.42)         0.933                 0.532--1.637   0.06       0.8098                  
  C           202(54.89)   186(54.07)        Ref                                                                     
  T           166(45.11)   158(45.93)        0.967                 0.720--1.300   0.05       0.82589                 
  rs3024496   CC           30(16.30)         21(12.21)             Ref                                               
  CT          66(35.87)    64(37.21)         0.722                 0.375--1.390   0.95       0.3287                  
  TT          88(47.83)    87(50.58)         0.708                 0.377--1.331   1.15       0.28277                 
  C           126(34.24)   106(30.81)        Ref                                                                     
  T           242(65.76)   238(69.19)        0.855                 0.625--1.171   0.95       0.32983                 
  rs3024498   AA           91(49.46)         46(26.74)             Ref                                               
  AG          55(29.89)    74(43.02)         0.376                 0.228--0.618   15.18      0.0001       0.0004     
  GG          38(20.65)    52(30.24)         0.369                 0.213--0.639   12.97      0.00032      0.0018     
  A           237(64.40)   166(48.26)        Ref                                                                     
  G           131(35.60)   178(51.74)        0.515                 0.382--0.696   18.87      0.00001      0.00004    

*In-Silico* approach for functional validation of rs3024498 {#sec010}
-----------------------------------------------------------

Bioinformatic analysis suggest four putative miRNA binding targets at rs3024498; miR-1236 (binding score 140, Δ G -9.20), miR-29b-2 (binding score 150, Δ G -13.80), miR-3192 (binding score 145, Δ G -23.90) and miR-4321 (binding score 140, Δ G -9.20) in wild type mRNA. In mutant, only three binding targets were found; miR-1236 (binding score 140, Δ G -9.20), miR-29b-2 (binding score 145, Δ G -11.20) and miR-3192 (binding score 141, Δ G -23.50).

IL10 variation in diverse Indian populations {#sec011}
--------------------------------------------

Analysis of four IL10 SNPs, observed in case-control study was analysed in 1138 subjects belong to 34 populations across India revealed variable frequency. The allele data of rs3024498 shows that 24 out of 34 populations have higher frequency (\>0.5) of G allele (mostly in tribal populations), and the remaining 10 populations showed high frequency of A allele (mostly in caste populations) ([Table 4](#pone.0124559.t004){ref-type="table"} and [Fig 4](#pone.0124559.g004){ref-type="fig"}).

![Geographical location and allele distribution of rs1518111 (2195 A\>G, intron), rs1554286 (2607 C\>T, intron) and rs3024498 (5311 A\>G) polymorphism in tribe and caste population of India.\
Population no. 1 to 16 belongs to castes (Fig A, C and E). Population no. 17 to 34 belongs to tribes (Fig B, D and F).](pone.0124559.g004){#pone.0124559.g004}
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###### Population characteristics (sample size, language family and social designation) and geographical location of studied *IL-10* loci rs1518111 (2195 A\>G, intron), rs1554286 (2607 C\>T, intron), rs3024496 (4976 T\>C, 3' UTR), rs3024498 (5311 A\>G, 3' UTR) in Indian population.
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  S.No.   Population characteristics with demographic details   rs1518111   rs1554286        rs302396   rs302398                                                                                                                
  ------- ----------------------------------------------------- ----------- ---------------- ---------- ----------------- ----------------------- ---------- ---------- ---------- ---------- ---------- ----------- ---------- -----------
  1       Tharu                                                 24          Indo-European    Tribal     Uttarakhand       29^°^23\'N/79^°^30\'E   0.46(22)   0.46(26)   0.60(29)   0.40(19)   0.17(8)    0.83(40)    0.23(11)   0.77(37)
  2       Gond                                                  24          Dravidian        Tribal     Jharkhand         22^°^67\'N/86^°^33\'E   0.46(22)   0.54(26)   0.48(23)   0.52(25)   0.23(11)   0.77(37)    0.06(3)    0.94(45)
  3       Ho (Jharkhand)                                        44          Austro-Asiatic   Tribal     Jharkhand         23°35\'N/85°33\'E       0.58(30)   0.42(22)   0.42(22)   0.58(30)   0.10(5)    0.90(47)    0.33(17)   0.67(35)
  4       Mahali (Jharkhand)                                    26          Austro-Asiatic   Tribal     Jharkhand         22°64\'N/86°30\'E       0.65(17)   0.35(9)    0.42(11)   0.58(15)   0.08(2)    0.92(24)    0.15(4)    0.85(22)
  5       Parhaiya                                              13          Austro-Asiatic   Tribal     Jharkhand         22°60\'N/86°36\'E       0.52(43)   0.48(39)   0.55(45)   0.45(37)   0.24(20)   0.76(62)    0.05(4)    0.95(78)
  6       Gond                                                  41          Dravidian        Tribal     Chhattisgarh      19°87\'N/81°60\'E       0.68(56)   0.32(26)   0.28(23)   0.72(59)   0.13(11)   0.87(71)    0.07(6)    0.93(76)
  7       Kharia                                                75          Austro-Asiatic   Tribal     Chhattisgarh      21°90\'N/83°40\'E       0.51(77)   0.49(73)   0.55(82)   0.45(68)   0.17(25)   0.83(125)   0.02(3)    0.98(147)
  8       Bhatudi                                               38          Indo-European    Tribal     Urissa            21°90\'N/86°70\'E       0.59(45)   0.41(31)   0.39(30)   0.61(46)   0.09(7)    0.91(69)    0.29(22)   0.71(54)
  9       Bhumij                                                41          Austro-Asiatic   Tribal     Urissa            21°93\'N/86°73\'E       0.68(56)   0.32(26)   0.34(28)   0.66(54)   0.22(18)   0.78(64)    0.26(21)   0.74(61)
  10      Ho (Urissa)                                           40          Austro-Asiatic   Tribal     Urissa            21°91\'N/86°74\'E       0.74(59)   0.26(21)   0.25(20)   0.75(60)   0.19(15)   0.81(65)    0.16(13)   0.84(67)
  11      Mahali (Urissa)                                       46          Austro-Asiatic   Tribal     Urissa            21°93\'N/86°73\'E       0.59(54)   0.41(38)   0.41(38)   0.59(54)   0.12(11)   0.88(81)    0.29(27)   0.71(65)
  12      Korkus                                                42          Austro-Asiatic   Tribal     Madhya Pradesh    22°06\'N/78°94\'E       0.67(56)   0.33(28)   0.32(27)   0.68(57)   0.14(12)   0.86(72)    0.13(11)   0.87(73)
  13      Warli                                                 59          Indo-European    Tribal     Maharastra        19°17\'N/72°95\'E       0.50(59)   0.50(59)   0.44(52)   0.56(66)   0.18(21)   0.82(97)    0.79(93)   0.21(25)
  14      Chenchu                                               20          Dravidian        Tribal     Andhra Pradesh    14°41\'N/77°39\'E       0.40(16)   0.60(24)   0.60(24)   0.40(16)   0.25(10)   0.75(30)    0.98(39)   0.03(1)
  15      Raj Gond                                              28          Dravidian        Tribal     Andhra Pradesh    19°67\'N/78°53\'E       0.48(27)   0.52(29)   0.52(29)   0.48(27)   0.23(13)   0.77(43)    0.00(0)    1.00(56)
  16      Kurumba                                               14          Dravidian        Tribal     Kerla             10°54\'N/76°27\'E       0.46(13)   0.54(15)   0.57(16)   0.43(12)   0.18(5)    0.82(23)    0.07(2)    0.93(26)
  17      Kashmiri Pandit                                       42          Indo-European    Caste      Jammu & Kashmir   34°22\'N/75°50\'E       0.42(35)   0.42(49)   0.62(52)   0.38(32)   0.26(22)   0.74(62)    0.40(34)   0.60(50)
  18      Pandit                                                33          Indo-European    Caste      Haryana           31°64\'N/74°86\'E       0.42(28)   0.42(38)   0.55(36)   0.45(30)   0.27(18)   0.73(48)    0.85(56)   0.15(10)
  19      Baiswar                                               37          Indo-European    Caste      Uttar Pradesh     25°15\'N/82°60\'E       0.36(27)   0.64(47)   0.62(46)   0.38(28)   0.35(26)   0.65(48)    0.95(70)   0.05(4)
  20      Brahman                                               36          Indo-European    Caste      Uttar Pradesh     25°73\'N/82°68\'E       0.43(31)   0.57(41)   0.46(33)   0.54(39)   0.40(29)   0.60(43)    0.79(57)   0.21(15)
  21      Srivastava                                            17          Indo-European    Caste      Uttar Pradesh     25°15\'N/82°60\'E       0.59(20)   0.41(14)   0.53(18)   0.47(16)   0.24(8)    0.76(26)    0.00(0)    1.00(34)
  22      Bhilala                                               41          Indo-European    Caste      Madhya Pradesh    22°60\'N/75°30\'E       0.63(55)   0.38(33)   0.22(19)   0.78(69)   0.13(11)   0.88(77)    0.10(9)    0.90(79)
  23      Gamit                                                 21          Indo-European    Caste      Gujrat            21°17\'N/72°83\'E       0.69(29)   0.31(13)   0.29(12)   0.71(30)   0.07(3)    0.93(39)    0.02(1)    0.98(41)
  24      Patkar                                                19          Dravidian        Caste      Andhra Pradesh    15°80\'N/78°10\'E       0.47(18)   0.53(20)   0.63(24)   0.37(14)   0.13(5)    0.87(33)    0.89(34)   0.11(4)
  25      Telagas                                               24          Dravidian        Caste      Andhra Pradesh    18°17\'N/83°53\'E       0.25(12)   0.75(36)   0.73(35)   0.27(13)   0.27(13)   0.73(35)    0.79(38)   0.21(10)
  26      Thoti                                                 34          Dravidian        Caste      Andhra Pradesh    16°51\'N/80°64\'E       0.37(25)   0.63(43)   0.62(42)   0.38(26)   0.16(11)   0.84(57)    0.91(62)   0.09(6)
  27      Pattapu kapu                                          23          Dravidian        Caste      Andhra Pradesh    15°83\'N/78°05\'E       0.43(20)   0.57(26)   0.57(26)   0.43(20)   0.22(10)   0.78(36)    0.07(3)    0.93(43)
  28      Naidu                                                 21          Dravidian        Caste      Andhra Pradesh    13°20\'N/79°11\'E       0.40(17)   0.60(25)   0.62(26)   0.38(16)   0.29(12)   0.71(30)    0.02(1)    0.98(41)
  29      Reddy                                                 22          Dravidian        Caste      Andhra Pradesh    17°37\'N/78°48\'E       0.25(11)   0.75(33)   0.75(33)   0.25(11)   0.27(12)   0.73(32)    0.05(2)    0.95(42)
  30      Vysya                                                 55          Dravidian        Caste      Andhra Pradesh    14°31\'N/77°44\'E       0.45(49)   0.55(61)   0.52(57)   0.48(53)   0.23(25)   0.77(85)    0.04(4)    0.96(106)
  31      Mala                                                  20          Dravidian        Caste      Andhra Pradesh    18°68\'N/78°10\'E       0.60(24)   0.40(16)   0.48(19)   0.53(21)   0.20(8)    0.80(32)    0.35(14)   0.65(26)
  32      AVDV (Karnataka)                                      25          Dravidian        Caste      Karnataka         12°58\'N/77°35\'E       0.48(24)   0.52(26)   0.60(30)   0.40(20)   0.30(15)   0.70(35)    0.84(42)   0.16(8)
  33      Adhi-dravider                                         59          Dravidian        Caste      Tamilnadu         11°35\'N/77°73\'E       0.43(51)   0.57(67)   0.62(73)   0.38(45)   0.19(23)   0.81(95)    0.43(51)   0.57(67)
  34      Mudaliar                                              34          Dravidian        Caste      Tamilnadu         12°92\'N/79°13\'E       0.59(40)   0.41(28)   0.53(36)   0.47(32)   0.16(11)   0.84(57)    0.88(60)   0.12(8)

The allele data of rs1554286 has shown that 20 out of 34 populations have higher frequency (\>0.5) of T allele (mostly tribes), 11 populations have high frequency of C allele (mostly castes) and three populations have an equal frequency of T and C alleles ([Table 4](#pone.0124559.t004){ref-type="table"} and [Fig 4](#pone.0124559.g004){ref-type="fig"}).

The allelic data of rs1518111 has shown that 16 out of 34 populations have higher frequency (\>0.5) of A allele (mostly in tribal populations) and the remaining 18 populations have high frequency of G allele (mostly in caste populations). The allelic data of rs3024496 shown that all the populations have higher frequency (\>0.5) of T allele ([Table 4](#pone.0124559.t004){ref-type="table"} and [Fig 4](#pone.0124559.g004){ref-type="fig"}).

Discussion {#sec012}
==========

Indian populations are highly diverse due to strict endogamy and show variations in allele frequency in general \[[@pone.0124559.ref037]\]. Cytokine polymorphisms are usually associated with disease progression. Therefore, our aim was to investigate the IL10 functional variants that can modulate or alter serum IL10 levels, which may leads to either increased or decreased risk for infectious disease on whole, VL in particular. Study suggest that about 50% of IL10 production is determined by genetic factors, whereas the other half is accounted by additive environmental influence \[[@pone.0124559.ref042]\].

We have found a total of 4 SNPs in individuals inhabited in VL endemic regions, of the four SNPs, rs3024498 showed association with VL. Although this SNP has been found to be associated with active pulmonary tuberculosis, colorectal cancer, helminth infection, gastrointestinal stromal tumours and hepatitis C virus (HCV) clearance \[[@pone.0124559.ref019], [@pone.0124559.ref043]--[@pone.0124559.ref046]\], we are reporting for the first time its association with Indian VL. It has been shown that Indian VL patients exhibit higher levels of *IL10* in serum \[[@pone.0124559.ref010], [@pone.0124559.ref012], [@pone.0124559.ref031]\]. Since we found g.5311A (A allele of rs3024498) is associated with VL, we predict that this might be regulating *IL10* production, either through *cis*-regulatory mechanism or in association (haplotype) with other promoter SNPs. Several studies have established that the *IL10* gene expression is regulated by complex mechanisms \[[@pone.0124559.ref047]--[@pone.0124559.ref050]\]. It has also been demonstrated that the rs3024498 showed similar risk effects in HCV clearance \[[@pone.0124559.ref046]\].

Haploview analysis of our case-control study shows that the SNP in intron 2 (rs1518111) is in linkage disequilibrium (r2 = 0.78; [Fig 3](#pone.0124559.g003){ref-type="fig"}) with the SNP in intron 3 (rs1554286). Although these two SNPs were not associated with VL in our study, but they were reported with Behcet's diseases in Han Chinese, Japan, Turkey and Korea populations \[[@pone.0124559.ref051], [@pone.0124559.ref052]\]. However, in India SNP rs1554286 has been found to be associated with leprosy \[[@pone.0124559.ref025]\].

India has one of the richest ethnic and linguistic diversity in South Asia and consists of more than four thousands of populations, including castes, tribes, primitive tribes and hunters and gatherers \[[@pone.0124559.ref037]\]. India is a home of several tribal pockets which represents 8.2% of the total population (2011 Census). The social structure of the Indian population is governed by the hierarchical caste system. We have demonstrated earlier that every single population in India is maintaining the endogamy for the last several thousand years, hence gained unique set of variations, which makes them genetically very distinct \[[@pone.0124559.ref037], [@pone.0124559.ref053]\]. In addition, we have also shown that the malaria susceptible allele is predominant in some populations, whereas others carry predominantly resistant allele \[[@pone.0124559.ref054], [@pone.0124559.ref055]\]. Having observed varying frequency of risk / resistant allele in different Indian populations, it would be worth to assess the frequency of all four IL10 polymorphisms, observed in the study, in 34 diverse Indian populations (1138 individuals, across India; [Table 4](#pone.0124559.t004){ref-type="table"}). We have observed over representation of protective allele (G of rs3024498) for VL, and risk allele (T of rs1554286) for leprosy among the tribal populations across India, and *vice versa* for caste populations ([Table 4](#pone.0124559.t004){ref-type="table"}, [Fig 4](#pone.0124559.g004){ref-type="fig"}). Interestingly, alleles A (rs1518111) that was found to be associated with Behcet's disease in Han Chinese population \[[@pone.0124559.ref051]\] was observed predominantly among the tribes while caste populations have higher frequency (\>0.50) of protected G allele.

Analysis of rs3024498 has shown that majority of tribal populations (14 out of 16), have high frequency of G allele (\>0.50). However, we found only two tribal groups (Chenchu 0.02%; and Warli 0.21%) are with low frequency of G allele, suggesting that these two populations were under higher risk of VL. Nevertheless, there is no VL case reported neither in these two populations, nor in these regions (Andhra Pradesh and Maharastra respectively) ([Table 4](#pone.0124559.t004){ref-type="table"}), which may be due to absence of Leishmania vector and non-favourable ecological conditions. Interestingly, although Chattisgarh, Jharkhand and Odisha states (tribes dominated states) were geographically closer to Bihar and majority of the populations inhabited in these states were genetically protected / frequency of risk alleles is lower (over- representation of G allele of SNP rs3024498). On the other hand, VL endemic / sporadic states (Bihar, West Bengal and Eastern part of Uttar Pradesh) were the caste dominated region and show over-representation of VL associated allele A. Our population data is in concordance with prevalence of VL in above or different states of India \[[@pone.0124559.ref056]\].

Comparison of the allele frequency of rs3024498 in different world populations showed that it varies across the populations. Interestingly, Gujarati Americans (American citizen with Indian ancestry) of HapMap Phase 3 (GIH) showed low frequency of MAF, compared to our study ([Table 5](#pone.0124559.t005){ref-type="table"}). This is mainly due to their admixure with the local American (37). Therefore, data of GIH should not be used as a representative data for Indian population. Analysis of rs3024496 has shown its association with helminth disease and chlamydial infection in Brazil and African populations, respectively \[[@pone.0124559.ref042], [@pone.0124559.ref047]\], however it is not associated with VL in our study. Although three SNPs (rs1518111, rs1554286 and rs3024498), out of four showed significant difference between caste and tribal populations, the fourth SNP (rs3024496) did not show any significant difference between caste and tribal populations.

10.1371/journal.pone.0124559.t005

###### Observed allele frequencies in the current study compared to reported allele frequencies in world populations.

![](pone.0124559.t005){#pone.0124559.t005g}

  Hap Map Database                          Populations                                 rs3024498 (A/G)   
  ----------------------------------------- ------------------------------------------- ----------------- ---------------
  This study                                Case                                        0.356 (131)       0.644 (237)
  Control                                   0.5174 (178)                                0.4826 (166)      
  Admix Indians                             Gujarati Indians in Houston, Texas. (GIH)   0.07386 (13)      0.92614 (163)
  Europeans                                 Toscans in Italy (TSI)                      0.1989 (35)       0.8011 (141)
  Cental European (CEU)                     0.2909 (64)                                 0.7091 (156)      
  Mexicans                                  Mexican ancestry in Los Angeles (MEX)       0.22 (22)         0.78 (78)
  E-Asians                                  Han-Chinese-(HCB)                           0 (0)             1 (164)
  Chinese in Metropolitan Denver, (CHD)     0.006024 (1)                                0.993976 (165)    
  Japanese in Tokyo (JPT)                   0 (0)                                       1 (172)           
  Africans                                  Luhya in Webuye, Kenya (LWK)                0.1278 (23)       0.8722 (157)
  Maasai in Kinyawa, Kenya. (MKK)           0.1573 (45)                                 0.8427 (241)      
  Yoruba (YRI)                              0.0885 (20)                                 0.9115 (206)      
  African ancestry in Southwest USA (ASW)   0.1146 (11)                                 0.8854 (85)       

Earlier studies on rs1554286 suggest its role in leprosy in North India, where the associated T allele makes haplotype with promoter SNP \[[@pone.0124559.ref025]\]. This SNP has been found to be associated with Behcets disease and down regulates *IL10* expression in juvenile rheumatoid arthritis \[[@pone.0124559.ref029], [@pone.0124559.ref052]\]. Analysis of leprosy risk allele T (rs1554286) in different Indian populations showed that majority of tribal populations (10 out of 16), have higher frequency (\>0.50%) of T allele compare to caste population (4 out of 18) ([Table 4](#pone.0124559.t004){ref-type="table"}). Our data is in concordance with earlier fact that tribe dominated states (Jharkhand, Chattisgarh and Odisha) were among the high leprosy incidence state in India according to World Health Organization ([www.who.int/lep/situation/india/states2006](http://www.who.int/lep/situation/india/states2006)) ([Table 6](#pone.0124559.t006){ref-type="table"}). Additionally, these states were also malaria endemic region \[[@pone.0124559.ref054]\]. Variation in rs1518111 was found to be associated with Behcet's disease in Han Chinese, Japan, Turkey and Korea populations \[[@pone.0124559.ref051], [@pone.0124559.ref052]\]. Allele wise data indicate that majority of tribal populations (11 out of 16) were showing high frequency (\>0.50%) of A allele, while majority of caste populations (13 out of 18) shows high frequency of G allele ([Table 4](#pone.0124559.t004){ref-type="table"}). Since study on Han Chinese population shows G allele as a protective allele, so we can conclude that castes population were resistance for Behcet's disease compare to tribes. Our data is in concordance to the fact that Behcet's disease is very rare in India due to caste dominated population of India (2011 Census).

10.1371/journal.pone.0124559.t006

###### Prevalence (yearly in millions) of different infectious disease (Visceral Leishmaniasis, Leprosy, Tuberculosis Malaria and Filaria) in worldwide and Indian region.

![](pone.0124559.t006){#pone.0124559.t006g}

  Diseases                 Prevalence in World   Prevalence in India   Disease burden by region (India-IN / south east asia-SEA)   Reference
  ------------------------ --------------------- --------------------- ----------------------------------------------------------- -------------------
  Visceral Leishmaniasis   \~ 0.2--0.4           \~ 0.28               \~67% (SEA)                                                 WHO; (5,38,39,56)
  Leprosy                  \~0.25                \~0.13                \~67 (SEA)                                                  WHO; (5,62)
  Tuberculosis             \~0.88                \~0.22                \~25% (IN)                                                  WHO; (5,63)
  Malaria                  \~207                 \~0.2                 \~77% of south east asia                                    WHO; (5,54,55,61)
  Filaria                  \~120                 \~21                  \~26%                                                       WHO; (5,64,65)

Furthermore, Haploview analysis of all four SNPs in 34 diverse Indian populations suggests that the LD varies from strong to moderate. The majority of the populations analysed (29 out of 34), showed LD between rs1518111 and rs1554286 (r2 \>0.5).

Several studies established IL10 as important anti-inflammatory cytokine, which modulate the VL susceptibility and resistance via Th2/T regulatory responses and considered it as a master regulator of immunity (reviewed in \[[@pone.0124559.ref009]\]). Earlier genetic study shows role of IL10 polymorphisms in VL, CL and PKDL in different world populations (Iran, Brazil and Sudan) \[[@pone.0124559.ref034]--[@pone.0124559.ref036]\]. In India various immunological studies in the same endemic region of Bihar, as the present study region, have demonstrated that VL patients have higher level of sera IL10, which is a key regulatory cytokine, involved in inhibition of parasite clearance \[[@pone.0124559.ref010], [@pone.0124559.ref032], [@pone.0124559.ref033]\]. Interestingly, our genetic study on the same ethnic populations, showed association of IL10 variation with VL (rs3024498; p = 0.00001). Since the same SNP (rs3024498) along with promoter SNP, was known to involve in phenotype regulation in other population \[[@pone.0124559.ref046]\], further analysis of promoter region will help in understanding whether the SNP-rs3024498 alone or in combination with any promoter SNP leads to VL risk / severity. Additionally, absence of miR-4321 binding sites and change of binding scores and free energy (miR-29b-2\* and miR-3192) in mutant-rs3024498 (A allele) suggest that this SNP might be dis-regulating the gene expression through improper miRNA binding, further affecting IL10 production and downstream functions of IL10. It is well established fact that genetic variants at miR binding sites are functional and important contributors to phenotype and diseases variation \[[@pone.0124559.ref057]--[@pone.0124559.ref060]\]. Presence of miR binding sites make this SNP relevant for further functional research. Since, diverse Indian populations were showing different frequency of risk alleles \[[@pone.0124559.ref054]--[@pone.0124559.ref055]\]. Therefore, we have to consider many populations or at least representative populations from different social and linguistic groups to assess the genetic basis of disease. India is one of major foci of VL, malaria, leprosy, tuberculosis and filarial infectious diseases however, presence of other less reported infectious disease in the region, feature a need for further research in this regard ([Table 6](#pone.0124559.t006){ref-type="table"}) \[[@pone.0124559.ref056], [@pone.0124559.ref061]--[@pone.0124559.ref067]\]. In above context, this study provides valuable information on IL10 variation in Indian populations with disease perspective and demonstrate *IL10* association with VL. Finally, identification of high-risk individuals / populations through genetic analysis will increase our understanding of the genetic basis of VL and to gain better insight in to the pathological basis of the severity of the disease. Thus, further, functional and replication study from other regions would support to conclude our findings.

Conclusion {#sec013}
==========

In conclusion, we have found a variant g.5311A in *IL10*, which is associated with Indian VL. Further, this comprehensive study on *IL10* in Indian populations have shown variable frequency of the disease associated variant in different populations, which is in concordance with our earlier findings that different social and linguistic populations of India have different genetic composition that determine the susceptibility or resistance or severity of the disease. Our finding has potential medical implications and this information can be used for generating data on the neglected diseases and would help in management and forecast of the severity of disease.
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